oleanolic acid has been researched along with Diabetic Retinopathy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, J; Liu, T; Shi, E; Wang, Y | 1 |
| Alrashdi, SF; de Haan, JB; Deliyanti, D; Meyer, C; Tan, SM; Ward, KW; Wilkinson-Berka, JL | 1 |
2 other study(ies) available for oleanolic acid and Diabetic Retinopathy
| Article | Year |
|---|---|
Network pharmacology study of the mechanism underlying the therapeutic effect of Zhujing pill and its main component oleanolic acid against diabetic retinopathy.
Topics: Animals; Diabetes Mellitus; Diabetic Retinopathy; Drugs, Chinese Herbal; Molecular Docking Simulation; Network Pharmacology; Oleanolic Acid; Vascular Endothelial Growth Factor A | 2023 |
Nrf2 Activation Is a Potential Therapeutic Approach to Attenuate Diabetic Retinopathy.
Topics: Angiopoietin-2; Animals; Blood-Retinal Barrier; Blotting, Western; Capillary Permeability; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Enzyme-Linked Immunosorbent Assay; Ependymoglial Cells; Gliosis; Interleukin-6; NF-E2-Related Factor 2; Oleanolic Acid; Oxidative Stress; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A | 2018 |